European Journal of Neurology · 2013 · 53 citations · 25 references
PharmacyNeurologyToxicologyHeavy Metal ToxicologyNeurodegenerationNeurotoxicologyBiomarkers Of NeurotoxicityHeavy Metal NeurotoxicityManganese ToxicityManganese ToxicologyOxidative Stress In NeurotoxicityParkinson DiseaseBlood Manganese BiomarkersBrain Manganese AccumulationHair Manganese BiomarkersInductively Coupled Plasma SpectrometryManganese OverexposureManganese PharmacokineticsManganese Status BiomarkersUrinary Manganese Biomarkers
BACKGROUND AND PURPOSE: Methcathinone abuse is a new cause of manganism. The psychostimulant is prepared from pseudoephedrine using potassium permanganate as an oxidant. We describe the clinical, biological, neuroimaging characteristics and follow-up results in a large Estonian cohort of intravenous methcathinone users. METHODS: During 2006-2012 we studied 38 methcathinone abusers with a mean age of 33 years. Subjects were rated by the Unified Parkinson's Disease Rating Scale (UPDRS), Hoehn and Yahr (HY), and Schwab and England (SE) rating scales. Twenty-four cases were reassessed 9-70 (20 ± 15) months after the initial evaluation. Manganese (Mn) in plasma and hair was analysed by inductively coupled plasma-atom emission spectrometry. Magnetic resonance imaging (MRI) was performed in 11, and single-photon emission computed tomography (SPECT) with iodobenzamide (IBZM) in eight subjects. RESULTS: The average total UPDRS score was 43 ± 21. The most severely affected domains in UPDRS Part III were speech and postural stability, the least affected domain was resting tremor. At follow-up there was worsening of HY and SE rating scales. Subjects had a higher mean level of Mn in hair (2.9 ± 3.8 ppm) than controls (0.82 ± 1.02 ppm), P = 0.02. Plasma Mn concentrations were higher (11.5 ± 6.2 ppb) in active than in former users (5.6 ± 1.8 ppb), P = 0.006. Active methcathinone users had increased MRI T1-signal intensity in the globus pallidus, substantia nigra and periaquaductal gray matter. IBZM-SPECT showed normal symmetric tracer uptake in striatum. CONCLUSION: Methcathinone abusers develop a distinctive hypokinetic syndrome. Though the biomarkers of Mn exposure are characteristic only of recent abuse, the syndrome is not reversible.
25
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
Irreversible motor impairment in young addicts ? ephedrone, manganism or both?
Katrin Sikk, Pille Taba, Sulev Haldre et al. · Acta Neurologica Scandinavica · 2007 · 664 citations
Medicine, Neurology, Toxicology +17
Manganese encephalopathy: utility of early magnetic resonance imaging.
Kari Nelson, J Golnick, Thomas Korn et al. · Occupational and Environmental Medicine · 1993 · 230 citations · Full text